Marketing-authorisation holder · United States
Santarus
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GLUMETZA1gm | 500mg · Tablet, extended release | Metformin | United States | Not marketed | 2005 |
| MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE343mg; 20mg; 750mg | 343mg; 40mg; 750mg · Tablet | Hydroxide, Omeprazole, Bicarbonate | United States | Not marketed | 2009 |
| ZEGERID20MG/PACKET; 1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG/PACKET; 1.68GM/PACKET | 40MG/PACKET; 1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For suspension | Omeprazole, Bicarbonate | United States | Not marketed | 2004 |
| ZEGERID700mg; 20mg; 600mg | 700mg; 40mg; 600mg · Tablet, chewable | Hydroxide, Omeprazole, Bicarbonate | United States | Not marketed | 2006 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States |